Stockreport

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF STRO-003 targets ROR1, a clinically validated antibody drug conjugate (ADC) target STRO-003 has shown robust monotherapy efficacy and potential for a differentiated s [Read more]